Evidence map›Paper›PMID 38821421›Full record

ArticlePreventive medicine2024

Electronic nicotine delivery systems (ENDS): Frequency of use and smoking-cessation efforts among U.S. women of reproductive age.

Sulamunn R M Coleman, Janice Y Bunn, Elias M Klemperer, Marc Jerome P Feinstein, Stephen T Higgins

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Preventive medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sulamunn R M ColemanVermont Center on Behavior and Health, University of Vermont, USA; Department of Psychiatry, University of Vermont, USA. Electronic address: sulamunn.coleman@uvm.edu.
Janice Y BunnVermont Center on Behavior and Health, University of Vermont, USA; Department of Medical Biostatistics, University of Vermont, USA.
Elias M KlempererVermont Center on Behavior and Health, University of Vermont, USA; Department of Psychiatry, University of Vermont, USA.
Marc Jerome P FeinsteinVermont Center on Behavior and Health, University of Vermont, USA; Department of Psychiatry, University of Vermont, USA.
Stephen T HigginsVermont Center on Behavior and Health, University of Vermont, USA; Department of Psychiatry, University of Vermont, USA; Department of Psychological Science, University of Vermont, USA.

Funding

University of Vermont Tobacco Center of Regulatory ScienceU54DA036114 · NIDA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HIGGINS, STEPHEN T · 2018 to 2022
$19.4M
TRAINING IN BEHAV. PHARMACOLOGY OF HUMAN DRUG DEPENDENCET32DA007242 · NIDA · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI HEIL, SARAH H, HIGGINS, STEPHEN T · 1990 to 2025
$8.2M
Vermont Center on Behavior and HealthP30GM149331 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Stephen T Higgins · 2023 to 2026
$5.6M
A randomized controlled trial of reduced nicotine cigarettes and e-cigarettes among dual usersR01DA059562 · NIDA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Elias M Klemperer · 2024 to 2026
$2.3M
NIDA NIH HHS R01 DA059562NIDA NIH HHS T32 DA007242NIDA NIH HHS U54 DA036114NIGMS NIH HHS P30 GM149331
6 · The paper itself

Abstract

objectiveReducing harm from combustible cigarette use among women of reproductive age (WRA) is critical given their potential vulnerability to multigenerational adverse impacts of cigarette smoking. Although electronic nicotine delivery systems (ENDS) are not approved smoking cessation aids in the US, many WRA who smoke report using ENDS to help quit smoking. Associations between ENDS use patterns and smoking-cessation efforts among US WRA remain unclear.

methodsUsing the Population Assessment of Tobacco and Health (PATH) Study, we examined whether baseline (Wave 3 or 4) ENDS use frequency predicted (a) making a cigarette quit attempt (QA) and (b) successful quitting by follow-up (Wave 4 or 5, respectively) among WRA (N = 2834; 72.1% non-Hispanic White).

resultsDaily ENDS use predicted greater adjusted odds of making a QA than non-daily (AOR = 1.63, 95% CI = 1.03, 2.59) and no ENDS use (AOR = 1.97, 95% CI = 1.23, 3.14), and greater odds of successful smoking cessation than non-daily use (AOR = 2.37, 95% CI = 1.31, 4.26). Daily ENDS use did not significantly improve odds of successful smoking cessation compared to no ENDS use (AOR = 1.62, 95% CI = 0.97, 2.69). Non-daily ENDS use did not significantly improve odds of making a QA (AOR = 1.21, 95% CI = 0.94, 1.56) and hindered successful smoking cessation compared to no ENDS use (AOR = 0.68, 95% CI = 0.48, 0.98).

conclusionsThese findings suggest that benefits of ENDS for smoking cessation in WRA may be greatest among those who use ENDS daily. WRA who choose to use ENDS to help quit would be well-informed by evidence that non-daily ENDS use may impede smoking cessation.

Indexed as

Electronic Nicotine Delivery SystemsSmoking CessationAdolescentAdultFemaleHumansMiddle AgedUnited StatesYoung AdultCombusted cigarettesDual useE-cigarettesENDSSmoking cessationWomen of reproductive age

Identifiers

PMID38821421
PMCPMC11563916

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.